Tuesday
Mar072000

NCT00004929

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase II

PrintView Printer Friendly Version

EmailEmail Article to Friend